Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Physiology|January 30, 2018
The Effects of Tai Chi Training in Patients with Heart Failure: A Systematic Review and Meta-AnalysisXiaomeng Ren, Yanda Li, Xinyu Yang, et al.
Cell Death & Disease|May 17, 2022
CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathwayLei Yang, Wenliang Tan, Yingcheng Wei, et al.
Nano Letters|June 4, 2025
Controlling Chirality and Stability of Gold Nanoclusters by PNP Pincer Ligand DiastereomersChun-Lian Lin, Xiaxi Lei, Ying Zhang, et al.
Surgery|July 31, 2023
A novel nomogram based on preoperative parameters to predict posthepatectomy liver failure in patients with hepatocellular carcinomaShuirong Lin, Zimin Song, Hong Peng, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 17, 2024
Metabolome-Wide Mendelian Randomization Assessing the Causal Relationship Between Blood Metabolites and Sarcopenia-Related TraitsSimin Chen, Yiran Dong, Nuerbiyamu Aiheti, et al.
Current Pharmaceutical Design|September 5, 2018
Mechanisms and Treatments of Oxidative Stress in Atrial FibrillationXiaomeng Ren, Xiaofeng Wang, Mengchen Yuan, et al.
Communications Biology|January 12, 2026
Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1Huilong Li, Ying Chen, Wanjin Shi, et al.
The Journal of Biological Chemistry|August 14, 2025
Real-Time Monitoring of Secretory Protein Traffic for Investigating Trafficking Regulators of ACE2 in Living CellsChang Zhang, Mengxin Yang, Yanzun An, et al.
Frontiers in Nutrition|May 15, 2024
A Mendelian randomization study to examine the causal associations of circulating micronutrient levels with frailty riskKaidiriyan Kuribanjiang, Yiping Min, Shikang Yan, et al.
Journal for Immunotherapy of Cancer|July 19, 2024
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapyYonglin Hua, Zhixian Sun, Yuxin Xiao, et al.
Pageof 5